BioPharma EHS Podcast – Episode #6

I2P2 and GHS are two of the major OSHA issues for 2011 that will be impacting health

Implement your injury illness and prevention program now

and safety programs in all industries in the United States, including the biotechnology and pharmaceutical industry.  In this episode of the BioPharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions provides a brief overview of what we might see in these two programs.  To listen in, please click on the player below or subscribe to the podcast via iTunes.

To submit questions or feedback to the podcast, please call our listener voicemail feedback line at 206-984-3214 or contact us at Affygility Solutions.


mm

About Dean Calhoun

view all posts

Dean is the President and CEO of Affygility Solutions. Affygility Solutions provides environmental, health and safety software, potent compound safety, industrial hygiene, containment validation services to the pharmaceutical, biotechnology, and medical device industry. "Dean's Google+ Profile"

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software